FDA Drug Application (205425) for LOPINAVIR AND RITONAVIR by CIPLA LTD

Back to FDA Applications sponsored by CIPLA LTD

Application Number205425
Product Number001
FormPELLETS;ORAL
Dosage40MG;10MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLOPINAVIR AND RITONAVIR
Active IngredientLOPINAVIR;RITONAVIR

Active IngredientCount
List of drugs with Active Ingredient LOPINAVIR3
List of drugs with Active Ingredient RITONAVIR11


Back to FDA Applications sponsored by CIPLA LTD